Literature DB >> 8655334

Cancer mortality among Techa River residents and their offspring.

M M Kossenko1.   

Abstract

This paper analyzes the data on leukemia and solid cancers of all types among 28,000 people exposed due to discharges of radioactive waste into the Techa River in the South Urals. Cancer mortality rates for the 33-y period since the beginning of the exposure have been estimated. In addition, the paper discusses malignancy cases among the first generation offspring of the exposed people. In comparison with matched control groups, an increased incidence of malignant neoplasms was observed among the exposed population. The leukemia risk, estimated on the basis of the linear model of absolute risk, was 0.85 per 10,000 person-y Gy of the dose accumulated in red bone marrow. Solid cancer risk (except osteosarcoma), estimated using linear model of relative risk, was 0.65 per Gy of dose accumulated in soft tissues. No increase in cancer mortality has been documented for the offspring of the exposed individuals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8655334     DOI: 10.1097/00004032-199607000-00012

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  3 in total

1.  Induction and persistence of radiation-induced DNA damage is more pronounced in young animals than in old animals.

Authors:  Darryl Hudson; Igor Kovalchuk; Igor Koturbash; Bryan Kolb; Olga A Martin; Olga Kovalchuk
Journal:  Aging (Albany NY)       Date:  2011-06       Impact factor: 5.682

Review 2.  The Russian radiation legacy: its integrated impact and lessons.

Authors:  M Goldman
Journal:  Environ Health Perspect       Date:  1997-12       Impact factor: 9.031

Review 3.  Overview of dose assessment developments and the health of riverside residents close to the "Mayak" PA facilities, Russia.

Authors:  William J F Standring; Mark Dowdall; Per Strand
Journal:  Int J Environ Res Public Health       Date:  2009-01-09       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.